Silicon Valley (PRASGLOFIN)
TurnaroundScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹0.03 |
| Market Cap | ₹0.39 Cr |
| P/E Ratio | 3.25 |
| ROCE | 0% |
| ROE | -56.02% |
| Dividend Yield | 0% |
| Profit Growth | 242.86% |
| Debt/Equity | — |
| Sales Growth | 0% |
| Promoter Holding | 2.74% |
| Sector | IT - Software |
Strengths
- Reported profit growth of +242.86% shows costs may have been brought down enough to generate nominal profits.
- Piotroski F-score of 5/9 indicates some financial health signals are positive.
- Software Products industry is theoretically scalable if real revenue ever emerges.
- Low absolute price and market cap make for a small, speculative penny-stock scale.
Concerns
- Latest quarter sales and net profit are ₹0 Cr, and sales growth is 0.00%—there is no demonstrated revenue engine.
- ROE is -56.02% and ROCE is 0.00%, indicating capital is being destroyed rather than compounded.
- Promoter holding is only 2.74%, meaning management has almost no ownership stake aligned with public shareholders.
- Book Value and Debt/Equity are N/A, so the company fails Graham's test of tangible asset backing and margin of safety.
AI Analysis
Let me be blunt: this is not the kind of business I would ever put in my portfolio. A price of ₹0.03 and a market cap of ₹0 Cr may look like a bargain, but cheap can become cheaper. The balance sheet is opaque—book value is N/A, debt-to-equity is N/A—and when I cannot see assets and liabilities, there is no margin of safety. The operating story is worse: sales growth is 0.00%, the latest quarter shows ₹0 Cr sales and ₹0 Cr profit, and return on equity is -56.02%. Return on capital employed is 0.00%. This is not an economic machine; it is a shell or a stalled software-products entity. The famous P/E of 3.25 is an illusion because earnings are effectively negligible. Likewise, the 242.86% 'profit growth' and 0.01 PEG ratio mean nothing from a base of zero or near-zero profits. Graham would insist on evidence of durable earnings power and able management. Here promoter holding is only 2.74%—the people running it have almost no skin in the game. There is no dividend to reward a patient holder. The only mildly positive signs are the Piotroski F-score of 5/9 and the fact that costs seem to have been cut enough to produce some positive nominal profit after a deeply negative ROE. That could be the start of a turnaround, or just financial engineering. Without audited numbers showing real revenue, positive book value, and a credible plan to generate cash from software products, I cannot value it. In Buffett's words, it is far better to buy a wonderful company at a fair price than a poor company at any price. This is a pass, unless the business genuinely changes.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer